What A Routine Blood Test Can Tell You About Your Survival Odds
This blood marker may reveal how resilient your body really is.
Konoly
Image by Klaus Vedfelt / Getty June 27, 2026 Most people think about muscle in terms of how they look or how much they can lift. But a growing body of research is reframing muscle as something far more fundamental: a biological reserve that may determine how well your body holds up when things go seriously wrong. A new study1 published in Frontiers in Nutrition adds to that idea. Researchers found that a simple blood test ratio, one that doctors already routinely order, may be linked to survival odds in critically ill patients with sepsis. The question is what that ratio is actually measuring, and what it might mean for the rest of us.
About the study
The study followed 1,103 patients admitted to an ICU with sepsis, a life-threatening condition in which the body's response to infection begins to damage its own tissues and organs. Researchers wanted to know whether a blood marker called the creatinine-to-cystatin C ratio (Cr/CysC ratio) was linked to whether patients survived the first 28 days.
Both creatinine and cystatin C are proteins measured in routine blood panels, typically used to assess kidney function. Researchers have increasingly recognized that their ratio may also serve as a rough indicator of muscle mass. Creatinine is a byproduct of muscle metabolism, so higher levels relative to cystatin C tend to reflect more muscle tissue. The ratio has been described in research as a "sarcopenia index," a way to estimate muscle loss without imaging.
Editor's note:
Creatinine and creatine are often confused for one another. Creatinine is produced through the breakdown of muscle tissue and the digestion of protein. Creatine is a compound made of amino acids that supports muscle with energy production, and has also been found to support brain health, bones, and more.
Patients with higher ratios were 56% less likely to die within 28 days
The 28-day mortality rate in the study was 29.9%. After accounting for other health factors, a higher Cr/CysC ratio was independently linked to a significantly lower risk of dying within 28 days. Patients with the highest ratio were about 56% less likely to die compared to those with the lowest ratio.
Patients who appeared to have more muscle mass when they arrived at the ICU were significantly more likely to survive the critical window following sepsis.
The researchers also found that this blood test could complement existing tools doctors already use to assess how sick a patient is, potentially helping clinicians identify higher-risk patients sooner, before outcomes deteriorate.
The study's authors note that in ICU patients with sepsis, both creatinine and cystatin C are strongly influenced by renal function, acute kidney injury, hemodynamic instability, and catabolic state. This means the Cr/CysC ratio likely reflects an interplay among muscle mass, kidney function, and overall illness severity rather than muscle mass alone. That complexity doesn't diminish the finding; it underscores how interconnected these systems are during critical illness.
How to build your reserves before you need them
None of this means you need to train like an athlete. But it does suggest that building and maintaining muscle now is one of the most meaningful investments you can make in your long-term health.
The takeaway
A routine blood test ratio may be linked to survival in critically ill sepsis patients, adding to a growing body of evidence that muscle is far more than a performance asset. The habits that protect it, including lifting weights, eating enough protein, and training consistently, are among the most evidence-backed investments you can make in long-term health.
